BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasatkina LA, Heinemann A, Hudz YA, Thomas D, Sturm EM. Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation. Biochem Pharmacol 2020;174:113783. [PMID: 31881191 DOI: 10.1016/j.bcp.2019.113783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Mock ED, Gagestein B, van der Stelt M. Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. Prog Lipid Res 2023;89:101194. [PMID: 36150527 DOI: 10.1016/j.plipres.2022.101194] [Reference Citation Analysis]
2 Kasatkina LA, Gumenyuk VP, Lisakovska OO, Trikash IO. Targeting hippocampal amyloidogenesis with SV2A protein modulator levetiracetam. Biochemical Pharmacology 2022;197:114927. [DOI: 10.1016/j.bcp.2022.114927] [Reference Citation Analysis]
3 Kasatkina LA, Rittchen S, Sturm EM. Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation. Int J Mol Sci 2021;22:5431. [PMID: 34063947 DOI: 10.3390/ijms22115431] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]